FIELD: pharmaceuticals.
SUBSTANCE: invention relates to the pharmaceutical industry and medicine, namely to the creation of a new, low-toxic (LD50 520 mg/kg), a biologically active substance having an anxiolytic and nootropic effect. .
EFFECT: new compound 2-ethyl-6-methyl-3-hydroxypyridine acetaxamate of structural formula (1) is proposed as an agent having an anxiolytic and nootropic effect.
1 cl, 2 dwg, 8 tbl
Title | Year | Author | Number |
---|---|---|---|
MEDICATION POSSESSING ANTIDEPRESSIVE, ANXIOLYTIC AND NOOTROPIC ACTION | 2010 |
|
RU2437659C1 |
PHENYLHYDRAZIDE (4-PHENYL-2-PYRROLIDON-1-YL)-ACETIC ACID, HAVING NOOTROPIC, ANTIDEPRESSANT AND ANXIOLYTIC ACTIVITY | 2010 |
|
RU2440981C1 |
QUINAZOLINE DERIVATIVES, POSSESSING ANTIDEPRESSANT, ANXIOLYTIC AND NOOTROPIC ACTIVITY | 2012 |
|
RU2507199C1 |
QUINAZOLINE DERIVATIVES, POSSESSING NOOTROPIC AND ANTIHYPOXIC ACTIVITY | 2012 |
|
RU2507198C1 |
4-[(4-ACETOXYBENZOYL)AMINO]BUTYRATE OF LITHIUM, HAVING CEREBROPROTECTIVE ACTION | 2015 |
|
RU2617233C2 |
2-ETHYL-6-METHYL-3-OXYPYRODINE SALTS WITH ORGANIC CARBOXYLIC ACIDS POSSESSING ANXIOLYTIC, ANTIDEPRESSIVE, ANTIHYPOXIC, ANTI-AMNESTIC AND ANTI-OXIDATIVE ACTIVITY AND METHOD FOR THEIR PREPARING | 2002 |
|
RU2284993C2 |
APPLICATION OF 1-HETARYL-2-NITRO-2-(3-PHENYL-1,2,4-OXADIAZOLE-5-YL)ETHANES AS PSYCHOTROPIC SUBSTANCES | 2009 |
|
RU2420521C1 |
WATER-SOLUBLE SALAMIDE DERIVATIVE POSSESSING TRANQUILISING, NOOTROPIC AND ANALGESIC ACTIVITY | 2012 |
|
RU2540464C2 |
SUBLINGUAL FORM OF 6-METHYL-2-ETHYL-3-HYDROXYPYRIDINE AND USING IT AS AGENT POSSESSING STIMULATING, ANORECTIC, ANTIDEPRESSANT, ANXIOLYTIC, ANTIHYPOXIC, ANTIAMNESTIC (NOOTROPIC), AND ANTIALCOHOL ACTIVITY | 2012 |
|
RU2527342C2 |
2-ETHYL-6-METHYL-3-HYDROXYPYRIDINE DICHLOROACETATE, ITS STABLE CRYSTALLINE FORM AND METHOD OF OBTAINING THEREOF | 2013 |
|
RU2540070C1 |
Authors
Dates
2018-08-17—Published
2017-11-24—Filed